Federal Court Enters Judgment Confirming RA Capital and Avilar Therapeutics Willfully and Maliciously Misappropriated Trade Secret Developed at Yale, Formalizing $4 Million Award to Biohaven and Yale University

Positive

AI Analysis

Summary

Federal court entered judgment in favor of Biohaven and Yale University against RA Capital and Avilar Therapeutics for willful and malicious misappropriation of a trade secret, formalizing a $4 million award.

Outcome Details

U.S. District Court for the District of Delaware entered judgment in favor of Biohaven and Yale University, confirming willful and malicious misappropriation of trade secret

Importance:5/10

Sentiment:

0.70

legalintellectual propertytrade secretlitigationjudgment

Related Companies

$BHVN

Read the original article

Published by PR Newswire Biotech on August 25, 2026 8:41 PM

Read Original